Bruker Acquires Electron Microscopy Company Nion
- Acquisition enhances Bruker's product offerings and technology portfolio in materials science research
- Nion introduces aberration correction for STEM instruments with ultra-high stability for highest resolution images
- Nion is the world leader in ultra-high energy and spatial resolution electron energy-loss spectroscopy (EELS)
- Nion had approximately $8 million in revenue in 2023
- None.
The acquisition of Nion by Bruker represents a strategic move to strengthen Bruker's position in the high-end materials science research market. The addition of Nion's advanced STEM technologies, particularly those with aberration correction and ultra-high energy resolution EELS, positions Bruker to capitalize on the growing demand for sophisticated materials analysis tools. The integration of these technologies could potentially open new revenue streams and enhance Bruker's competitive edge in the electron microscopy market.
While financial details were not disclosed, Nion's reported revenue of approximately $8 million in 2023 provides a glimpse into the scale of the acquisition. It's important to consider the synergy between the two companies and how Bruker's global market reach could amplify Nion's sales. The collaboration on new developments in electron diffraction crystallography could also lead to innovative products, further solidifying Bruker's market presence and possibly creating a ripple effect in terms of increased market share and revenue growth.
The undisclosed financial details of Bruker's acquisition of Nion leave some uncertainty for stakeholders, but the revenue figure for Nion offers a basis for evaluating the deal's materiality. Given Bruker's status as a publicly-traded company, the market will likely focus on the acquisition's impact on earnings, R&D efficiencies and any potential cost synergies. Investors should monitor future financial statements for amortization of intangible assets, potential goodwill adjustments and R&D capitalization that may affect Bruker's balance sheet and income statement.
Long-term, the acquisition may enhance Bruker's EBITDA margins if the integration process is managed effectively and if the new technologies lead to product differentiation. However, the lack of financial details requires careful observation of the acquisition's incremental impact on Bruker's overall financial health.
From a technical standpoint, the acquisition of Nion's high-end STEM and EELS technologies is significant. Aberration correction in STEM allows for unprecedented resolution in imaging, which is critical for advanced materials research. Ultra-high energy resolution EELS provides detailed information about the electronic structure and properties of materials at the atomic level. These capabilities are essential for cutting-edge research in fields like nanotechnology, semiconductor development and materials engineering.
Bruker's expansion into electron diffraction crystallography, facilitated by this acquisition, indicates a commitment to advancing materials characterization techniques. This move could have implications for the development of new materials with tailored properties, potentially impacting industries ranging from electronics to pharmaceuticals. The scientific community may benefit from improved access to state-of-the-art instrumentation through Bruker's established distribution channels.
High-end STEM Technology Expands Bruker’s Portfolio for Materials Science Research
Located in
“We are excited to add the high-end STEM products, the electron microscopy technology, and this new expertise of Nion to Bruker,” said Dr. Frank Burgaezy, the Bruker AXS division president. “Nion has unique products for the most demanding research applications in materials science electron microscopy, and Bruker will offer Nion global market reach as well as collaborations on new developments to enter new applications in electron diffraction crystallography based on Nion electron microscope and Bruker crystallography technologies.”
“With the introduction of aberration correction and ultra-high energy resolution EELS, Nion has revolutionized STEM technology. With our products we have established an excellent reputation among leading scientists around the globe as a provider of high-end STEM products,” added Dr. Ondrej Krivanek, co-founder of Nion. “Our work has given us unique insights into what researchers need. We are very gratified to join Bruker, an internationally esteemed instrumentation company, whose philosophy, culture, and reputation align very closely with our company culture and our research-oriented goals.”
About Nion
Nion is a world-class developer of advanced scanning transmission electron microscopes (the UltraSTEM™ range) and other electron-optical instruments. Since its founding 26 years ago, Nion has been a major force in advancing the state of the art in electron microscopy, in close collaboration with their customers. The company designs and makes state-of-the art cold field emission guns, aberration correctors, monochromators, sample stages, spectrometers, and detectors. This allows the company to ensure that all the components work together seamlessly, and to deliver world-class instruments that answer needs in the real world, in an integrated and easy-to-use manner.
About Bruker Corporation (NASDAQ: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240103293510/en/
Investor:
Justin Ward
Sr. Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com
Media:
Dr. Heiko Ress
Bruker AXS Director Marketing Communications
T: +(49) 721 50997-0
E: heiko.ress@bruker.com
Source: Bruker Corporation
FAQ
What did Bruker Corporation (BRKR) acquire?
What is Nion known for in the field of STEM technology?
How much revenue did Nion generate in 2023?
Where is Nion located?
Who founded Nion?
